Business Context and Reporting Period
This Form 8-K is filed by MEI Pharma, Inc. (not Lite Strategy, Inc.) for the reporting period of November 19, 2012. The company is a Delaware corporation headquartered in San Diego, California.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses on corporate governance and capital structure events rather than operational financial performance.
Material Changes
- Unregistered Sales of Equity Securities: On November 19, 2012, Novogen Limited converted all 1,000 shares of Series A Convertible Preferred Stock into 4,827,000 shares of common stock. This conversion was executed on November 20, 2012, pursuant to an Asset Purchase Agreement from December 2010.
- Reverse Stock Split Approval: The Board of Directors approved a modification to a previously announced reverse stock split. The new terms allow the Board discretion to set a split ratio between 1-for-2 and 1-for-10. Novogen, holding a majority of outstanding common stock, executed a written consent to this modification on November 19, 2012.
Guidance, Outlook, and Risks
Management expects the reverse stock split to become effective in December 2012, contingent upon the mailing of a definitive information statement and the passage of 20 days. However, the filing explicitly states there is no assurance that the split will be consummated or achieve its intended effects. The company reserves the right to abandon the reverse stock split at any time prior to filing the amendment with the Delaware Secretary of State.
Investor Verification Checklist
- Verify the exact reverse stock split ratio once the Board determines it within the 1-for-2 to 1-for-10 range.
- Confirm the filing and effectiveness date of the amendment to the Restated Certificate of Incorporation.
- Review the definitive information statement for additional details on the reverse stock split mechanics.
- Monitor for any announcement regarding the abandonment of the reverse stock split.